Reuters logo
BRIEF-Akebia Therapeutics enters into a license agreement with Otsuka Pharmaceutical
April 25, 2017 / 8:56 PM / 5 months ago

BRIEF-Akebia Therapeutics enters into a license agreement with Otsuka Pharmaceutical

April 25 (Reuters) - Akebia Therapeutics Inc:

* Says entered into a collaboration and license agreement ( 'agreement') with Otsuka Pharmaceutical Co Ltd Source text:(bit.ly/2q40fPR) Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below